These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6690009)

  • 1. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF; Fritsche HA; Samaan NA
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma.
    Rougier P; Calmettes C; Laplanche A; Travagli JP; Lefevre M; Parmentier C; Milhaud G; Tubiana M
    Cancer; 1983 Mar; 51(5):855-62. PubMed ID: 6821852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
    Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
    Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
    Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
    Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
    Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
    Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
    Norton JA; Doppman JL; Brennan MF
    Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
    Papapetrou PD; Polymeris A
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of calcitonin and carcinoembryonic antigen in long-term organ culture of human medullary thyroid carcinoma: biochemical and immunocytochemical studies.
    Raue F; Boller G; Rix E; Schmidt-Gayk H; Ziegler R
    Klin Wochenschr; 1985 Mar; 63(5):205-10. PubMed ID: 3990162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
    Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma.
    Yokoi K; Imai T; Shibata A; Hibi Y; Kikumori T; Funahashi H; Nakao A
    Endocr J; 2003 Aug; 50(4):453-8. PubMed ID: 14599120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.
    Ishikawa N; Hamada S
    Br J Cancer; 1976 Aug; 34(2):111-5. PubMed ID: 962990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers in C-cell cancer].
    Raue F; Schmidt-Gayk H; Ziegler R
    Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.